1. Home
  2. BIO vs LEGN Comparison

BIO vs LEGN Comparison

Compare BIO & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$264.92

Market Cap

7.1B

Sector

Industrials

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$17.41

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIO
LEGN
Founded
1952
2014
Country
United States
United States
Employees
7450
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
5.9B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BIO
LEGN
Price
$264.92
$17.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
13
Target Price
$358.50
$63.08
AVG Volume (30 Days)
235.7K
1.5M
Earning Date
04-30-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2.74
$46.27
Revenue Next Year
$3.05
$28.77
P/E Ratio
$9.72
N/A
Revenue Growth
N/A
N/A
52 Week Low
$211.43
$16.24
52 Week High
$343.12
$45.30

Technical Indicators

Market Signals
Indicator
BIO
LEGN
Relative Strength Index (RSI) 40.24 39.55
Support Level $239.33 $16.24
Resistance Level $289.61 $20.39
Average True Range (ATR) 7.46 0.80
MACD 0.44 -0.09
Stochastic Oscillator 19.99 0.83

Price Performance

Historical Comparison
BIO
LEGN

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: